This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Donatienne Denni-Dischert: Innovator in Pharmaceutical Chemistry
Introduction
Donatienne Denni-Dischert is a prominent inventor based in Wettolsheim, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on epothilone derivatives. Her research has the potential to impact cancer treatment and other medical applications.
Latest Patents
Denni-Dischert holds a patent for her invention titled "Epothilone derivatives." This patent relates to C4-demethyl-epothilones or C4-bisnor-epothilones of Formula (I), detailing their pharmaceutical use, pharmaceutical compositions containing these compounds, and methods for their preparation. She has 1 patent to her name, showcasing her expertise in this specialized area.
Career Highlights
Throughout her career, Denni-Dischert has been associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in pharmaceuticals.
Collaborations
Some of her notable coworkers include Andreas Floersheimer and Ernst Kuesters. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Donatienne Denni-Dischert is a trailblazer in the field of pharmaceutical chemistry, with her work on epothilone derivatives paving the way for future advancements in cancer treatment. Her contributions to Novartis AG and the pharmaceutical industry highlight her importance as an inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile